Innovative peptide architectures: advancements in foldamers and stapled peptides for drug discovery.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Innovative peptide architectures: advancements in foldamers and stapled peptides for drug discovery.
- Published In:
- Expert opinion on drug discovery, 19(6), 699-723 (2024)
- Authors:
- Dongrui, Zhou, Miyamoto, Maho, Yokoo, Hidetomo(4), Demizu, Yosuke
- Database ID:
- RPEP-08102
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-08102APA
Dongrui, Zhou; Miyamoto, Maho; Yokoo, Hidetomo; Demizu, Yosuke. (2024). Innovative peptide architectures: advancements in foldamers and stapled peptides for drug discovery.. Expert opinion on drug discovery, 19(6), 699-723. https://doi.org/10.1080/17460441.2024.2350568
MLA
Dongrui, Zhou, et al. "Innovative peptide architectures: advancements in foldamers and stapled peptides for drug discovery.." Expert opinion on drug discovery, 2024. https://doi.org/10.1080/17460441.2024.2350568
RethinkPeptides
RethinkPeptides Research Database. "Innovative peptide architectures: advancements in foldamers ..." RPEP-08102. Retrieved from https://rethinkpeptides.com/research/dongrui-2024-innovative-peptide-architectures-advancements
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.